<DOC>
	<DOCNO>NCT00072540</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development cancer . Celecoxib may effective prevent cervical cancer . PURPOSE : Randomized phase II trial study effectiveness celecoxib prevent cervical cancer patient high-grade squamous intraepithelial lesion cervix .</brief_summary>
	<brief_title>S0212 Celecoxib Treating Patients With High-Grade Squamous Intraepithelial Lesions Cervix</brief_title>
	<detailed_description>OBJECTIVES : - Compare complete response rate patient high-grade squamous intraepithelial lesion cervix treat celecoxib v placebo . - Compare toxicity drug patient . - Determine , preliminarily , effect celecoxib cyclooxygenase-2 expression human papilloma virus expression patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord high-grade squamous intraepithelial lesion status ( cervical intraepithelial neoplasia [ CIN ] 2 v CIN 3 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral celecoxib twice daily 1 month . - Arm II : Patients receive oral placebo twice daily 1 month . In arm , treatment repeat monthly 3 course absence disease progression unacceptable toxicity . All patient undergo loop electrosurgical excision procedure cone biopsy determine response . PROJECTED ACCRUAL : A total 100 patient ( 50 per treatment arm ) accrue study within 1-2 year .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm highgrade squamous intraepithelial lesion ( HGSIL ) cervix Cervical intraepithelial neoplasia ( CIN ) 2 ( moderate dysplasia ) OR CIN 3 ( severe dysplasia , carcinoma situ ) Must remain HGSIL biopsy No suspicion invasive cancer colposcopy within past 28 day No invasive preinvasive highgrade intraepithelial neoplasia endocervical curettage within past 56 day PATIENT CHARACTERISTICS : Age 18 Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Not specify Hepatic SGOT SGPT less 2.0 time upper limit normal ( ULN ) Bilirubin le 2.0 time ULN Renal Creatinine le 2.0 mg/dL Immunologic No prior asthma , urticaria , allergictype reaction aspirin NSAIDs No allergy sulfonamides No known sensitivity celecoxib No known AIDS HIVassociated complex Other Not pregnant nursing Fertile patient must use effective contraception No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer adequately treat stage I II cancer currently complete remission PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy No prior pelvic radiotherapy Surgery See Disease Characteristics Other More 3 month since prior topical medication genital condyloma No prior treatment squamous intraepithelial lesion No concurrent topical medication genital condyloma No concurrent treatment No concurrent chronic ( daily 30 day ) aspirin No concurrent nonsteroidal antiinflammatory drug ( NSAIDs )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>